134 related articles for article (PubMed ID: 6461438)
41. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
42. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
[TBL] [Abstract][Full Text] [Related]
43. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
44. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
Pelzer H; Schwarz A; Heimburger N
Thromb Haemost; 1988 Feb; 59(1):101-6. PubMed ID: 3363526
[TBL] [Abstract][Full Text] [Related]
45. Role of heparin in the interaction of serine proteinases with antithrombin III.
Stürzebecher J
Acta Biol Med Ger; 1977; 36(11-12):1893-7. PubMed ID: 151469
[TBL] [Abstract][Full Text] [Related]
46. A sensitive colorimetric assay for various proteases using naphthyl ester derivatives as substrates.
Niinobe M; Hitomi Y; Fujii S
J Biochem; 1980 Mar; 87(3):779-83. PubMed ID: 6446549
[TBL] [Abstract][Full Text] [Related]
47. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
[TBL] [Abstract][Full Text] [Related]
48. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis.
Reeve EB
Thromb Res; 1980 Apr 1-15; 18(1-2):19-31. PubMed ID: 6157218
[No Abstract] [Full Text] [Related]
49. Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
Gallistl S; Muntean W
Thromb Haemost; 1994 Sep; 72(3):387-92. PubMed ID: 7855789
[TBL] [Abstract][Full Text] [Related]
50. Xenogeneic endothelial cells activate human prothrombin.
Siegel JB; Grey ST; Lesnikoski BA; Kopp CW; Soares M; Schulte am Esch J; Bach FH; Robson SC
Transplantation; 1997 Sep; 64(6):888-96. PubMed ID: 9326416
[TBL] [Abstract][Full Text] [Related]
51. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
52. Identification of a congenital dysthrombin, thrombin Quick.
Henriksen RA; Owen WG; Nesheim ME; Mann KG
J Clin Invest; 1980 Nov; 66(5):934-40. PubMed ID: 6776145
[TBL] [Abstract][Full Text] [Related]
53. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
54. Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin.
Bezeaud A; Drouet L; Soria C; Guillin MC
Thromb Res; 1984 Jun; 34(6):507-18. PubMed ID: 6377575
[TBL] [Abstract][Full Text] [Related]
55. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
56. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
57. Synthetic peptide substrates in hemostatic testing.
Fareed J; Messmore HL; Walenga JM; Bermes EW
Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
[TBL] [Abstract][Full Text] [Related]
58. Thrombosis and hormone replacement therapy in postmenopausal women.
Saleh AA; Dorey LG; Dombrowski MP; Ginsburg KA; Hirokawa S; Kowalczyk C; Hirata J; Bottoms S; Cotton DB; Mammen EF
Am J Obstet Gynecol; 1993 Dec; 169(6):1554-7. PubMed ID: 8267061
[TBL] [Abstract][Full Text] [Related]
59. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
Collen D
Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
[No Abstract] [Full Text] [Related]
60. Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.
Zoldhelyi P; Bichler J; Owen WG; Grill DE; Fuster V; Mruk JS; Chesebro JH
Circulation; 1994 Dec; 90(6):2671-8. PubMed ID: 7994807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
